3 documents

Cumberland disclosed in its 2Q12 earnings that Health Canada approved Caldolor ibuprofen to treat pain and fever. The company said that marketing partner Alveda Pharmaceuticals Inc. (Toronto, Ontario) began "launch activities" in Canada for the...

Cumberland granted Alveda an exclusive license to commercialize Caldolor ibuprofen in Canada. Alveda will be responsible for obtaining regulatory approval in Canada. Cumberland will receive an undisclosed upfront payment and will be eligible for milestones...